Longevity Investors & VC Firms in Asia-Pacific
16 firms in this list, with a median first check of $700K. 5 of them lead rounds. Generated from verified public data and updated continuously.
OrbiMed
New YorkPre-Seed–Late Stage$1M – $75M
126 people
Novo Holdings
CopenhagenPre-Seed–Late Stage$1.1M – $54M
42 people
MPM BioImpact
BostonPre-Seed–Series C$1M – $15M
40 people
DOMiNO Ventures
AmsterdamSeed–Series B$220K – $1.1M
30 people
ClavystBio
SingaporeSeed–Series A
33 people
Kinled Holding
Hong KongSeed–Series A
1 person
Brookstreet Equity Partners
LondonPre-Seed–Growth
20 people
Lifetime Ventures
OkinawaPre-Seed–Growth
5 people
Overwater Ventures Llc
Palo AltoPre-Seed–Series A$400K – $2M
7 people
Fab Co-Creation Studio Ventures
San FranciscoPre-Seed–Series A$250K – $1M
1 person
Blueprint Ventures (SEA)
7 people
Reech Corporations Group
Dubai
10 people
Seveno Capital
SingaporePre-Seed–Growth
2 people
10K Ventures
BerlinPre-Seed–Seed$100K – $200K
2 people
Elmirate Capital
DubaiSeed–Late Stage$15M – $150M
Bioscience Equity Partners
DubaiLate Stage
1 person
Related lists
Investors & VC Firms in United States (5050)Crypto & Web3 Investors & VC Firms (4688)Investors & VC Firms in Global (4044)SaaS Investors & VC Firms (3602)AI & Machine Learning Investors & VC Firms (3577)Fintech Investors & VC Firms (3506)Healthtech Investors & VC Firms (3208)Enterprise Software Investors & VC Firms (3098)Investors & VC Firms in Europe (2833)Consumer Investors & VC Firms (2381)
Data sourced from public filings and firms' own websites — see our methodology.










































